The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea

Diabetologia

Volumn 49, Issue 4, 2006, Pages 629-636

  Mueller, C ^a   Laule Kilian, K ^a   Christ, A ^a   Perruchoud, A P ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diabetes; Dyspnoea; Emergency diagnosis; Natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DYSPNEA; FEMALE; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; DYSPNEA; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE; TREATMENT OUTCOME;

EID: 33644825398     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0149-z     Document Type: Article

References (30)

1. Hunt SA, Baker DW, Chin MH et al (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 104:2996-3007
2. Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Eur Heart J 22:1527-1560
3. American Thoracic Society (1999) Dyspnea. Mechanisms, assessment, and management: a consensus statement Am J Respir Crit Care Med 159:321-340
4. American Heart Association (2003) Heart disease and stroke statistics, 2003 update. American Heart Association, Dallas, 2002
5. Bales AC, Sorrentino MJ (1997) Causes of congestive heart failure: prompt diagnosis may affect prognosis. Postgrad Med 101:44-49, 54-56
6. Wuerz RC, Meador SA (1992) Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med 21:669-674
7. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29-34
8. Devereux RB, Roman MJ, Paranicas M et al (2000) Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101:2271-2276
9. Spector KS (1998) Diabetic cardiomyopathy. Clin Cardiol 21:885-887
10. Bell DSH (2003) Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26:2433-2441
11. Bell DSH (2004) Heart failure: a serious and common comorbidity of diabetes. Clin Diabetes 22:61-65
12. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 289:194-202
13. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG (2001) Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes. Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:5-10
14. Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-167
15. Davis M, Espiner E, Richards G et al (1994) Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343:440-444
16. Maisel AS, McCord J, Nowak RM et al (2003) Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41:2010-2017
17. McCullough PA, Duc P, Omland T et al (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41:571-579
18. Mueller C, Laule Kilian K, Scholer A et al (2005) B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison. Kidney Int 67:278-284
19. Mueller C, McHodgson JB, Brutsche M et al (2002) Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics - insights from the randomized SIPS trial. Swiss Med Wkly 132:279-284
20. Mueller C, Neumann FJ, Ferenc M, Perruchoud AP, Buettner HJ (2004) Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with very early revascularisation. Diabetologia 47:1188-1195
21. Wright SP, Doughty RN, Pearl A et al (2003) Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care. A randomized, controlled trial. J Am Coll Cardiol 42:1793-1800
22. Mueller C, Scholer A, Laule Kilian K et al (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350:647-654
23. Cheng V, Kazanagra R, Garcia A et al (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37:386-391
24. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Heath and Medicine (1996) Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276:1253-1258
25. Siegel JE, Weinstein MC, Russell LB, Gold MR, for the Panel on Cost-Effectiveness in Heath and Medicine (1996) Recommendations for reporting cost-effectiveness analysis. JAMA 276:1339-1341
26. Yano Y, Katsuki A, Gabazza EC et al (1999) Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 84:2353-2356
27. Epshteyn V, Morrison K, Krishnaswamy P et al (2003) Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26:2081-2087
28. Nagai T, Imamura M, Inukai T, Mori M (2001) Brain natriuretic polypeptide in type 2 NIDDM patients with albuminuria. J Med 32:169-180
29. Wu AHB, Omland T, Duc P et al (2004) The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea. Diabetes Care 2398-2404
30. Wang TJ, Larson MG, Levy D et al (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594-600